These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 20182037

  • 1. Caffeine and coffee as therapeutics against Alzheimer's disease.
    Arendash GW, Cao C.
    J Alzheimers Dis; 2010; 20 Suppl 1():S117-26. PubMed ID: 20182037
    [Abstract] [Full Text] [Related]

  • 2. Caffeine reverses cognitive impairment and decreases brain amyloid-beta levels in aged Alzheimer's disease mice.
    Arendash GW, Mori T, Cao C, Mamcarz M, Runfeldt M, Dickson A, Rezai-Zadeh K, Tane J, Citron BA, Lin X, Echeverria V, Potter H.
    J Alzheimers Dis; 2009; 17(3):661-80. PubMed ID: 19581722
    [Abstract] [Full Text] [Related]

  • 3. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J.
    Neuroscience; 2006 Nov 03; 142(4):941-52. PubMed ID: 16938404
    [Abstract] [Full Text] [Related]

  • 4. Caffeine synergizes with another coffee component to increase plasma GCSF: linkage to cognitive benefits in Alzheimer's mice.
    Cao C, Wang L, Lin X, Mamcarz M, Zhang C, Bai G, Nong J, Sussman S, Arendash G.
    J Alzheimers Dis; 2011 Nov 03; 25(2):323-35. PubMed ID: 21422521
    [Abstract] [Full Text] [Related]

  • 5. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, Arendash GW, Bradshaw PC.
    J Alzheimers Dis; 2010 Nov 03; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [Abstract] [Full Text] [Related]

  • 6. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW, Jensen MT, Salem N, Hussein N, Cracchiolo J, Dickson A, Leighty R, Potter H.
    Neuroscience; 2007 Oct 26; 149(2):286-302. PubMed ID: 17904756
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J, Luo H, Yan B, Yu Y, Wang H, Wei Z, Zhang Y, Xu H, Tempier A, Li X, Li XM.
    Neurobiol Aging; 2009 Aug 26; 30(8):1205-16. PubMed ID: 18079026
    [Abstract] [Full Text] [Related]

  • 8. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I, Arbel M, Solomon B.
    Neurodegener Dis; 2007 Aug 26; 4(5):392-402. PubMed ID: 17536186
    [Abstract] [Full Text] [Related]

  • 9. Use of artificial neural networks to determine cognitive impairment and therapeutic effectiveness in Alzheimer's transgenic mice.
    Leighty RE, Runfeldt MJ, Berndt DJ, Schleif WS, Cracchiolo JR, Potter H, Arendash GW.
    J Neurosci Methods; 2008 Jan 30; 167(2):358-66. PubMed ID: 17904642
    [Abstract] [Full Text] [Related]

  • 10. Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease.
    Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW.
    J Pineal Res; 2009 Aug 30; 47(1):82-96. PubMed ID: 19538338
    [Abstract] [Full Text] [Related]

  • 11. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
    Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, Sun X, Zhao L, Yu M, Xu Z, Dong W, Qin Y, Fei G, Zhong C, Xu TL.
    Brain; 2010 May 30; 133(Pt 5):1342-51. PubMed ID: 20385653
    [Abstract] [Full Text] [Related]

  • 12. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G, Zhu A, Holsinger RM, Masters CL, Li QX.
    J Neurosci Res; 2003 Nov 01; 74(3):386-92. PubMed ID: 14598315
    [Abstract] [Full Text] [Related]

  • 13. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R, Disterhoft JF.
    Eur J Neurosci; 2006 Jan 01; 23(1):251-60. PubMed ID: 16420434
    [Abstract] [Full Text] [Related]

  • 14. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
    Srivareerat M, Tran TT, Alzoubi KH, Alkadhi KA.
    Biol Psychiatry; 2009 Jun 01; 65(11):918-26. PubMed ID: 18849021
    [Abstract] [Full Text] [Related]

  • 15. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O.
    Ann Neurol; 2004 Jun 01; 55(6):801-14. PubMed ID: 15174014
    [Abstract] [Full Text] [Related]

  • 16. Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor.
    Barten DM, Guss VL, Corsa JA, Loo A, Hansel SB, Zheng M, Munoz B, Srinivasan K, Wang B, Robertson BJ, Polson CT, Wang J, Roberts SB, Hendrick JP, Anderson JJ, Loy JK, Denton R, Verdoorn TA, Smith DW, Felsenstein KM.
    J Pharmacol Exp Ther; 2005 Feb 01; 312(2):635-43. PubMed ID: 15452193
    [Abstract] [Full Text] [Related]

  • 17. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging.
    Jensen MT, Mottin MD, Cracchiolo JR, Leighty RE, Arendash GW.
    Neuroscience; 2005 Feb 01; 130(3):667-84. PubMed ID: 15590151
    [Abstract] [Full Text] [Related]

  • 18. Caffeine as a protective factor in dementia and Alzheimer's disease.
    Eskelinen MH, Kivipelto M.
    J Alzheimers Dis; 2010 Feb 01; 20 Suppl 1():S167-74. PubMed ID: 20182054
    [Abstract] [Full Text] [Related]

  • 19. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
    Toledo EM, Inestrosa NC.
    Mol Psychiatry; 2010 Mar 01; 15(3):272-85, 228. PubMed ID: 19621015
    [Abstract] [Full Text] [Related]

  • 20. Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
    Dall'Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR.
    Exp Neurol; 2007 Jan 01; 203(1):241-5. PubMed ID: 17007839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.